RxDoctor Payments Data

Anthony Whitney, MD

Family Medicine · Cleveland, TNNPI 1700897394

Payments from drug & device makers

$3,212in general payments, 2019–2025

Across 195 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$364
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
  • AstraZeneca$204
  • Abbott$198
  • Pfizer$184
  • plus $933 from 23 others

What the payments were for

  • Food & beverage$3,212100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,212 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$203,585
Medicare patients
379
Services billed
2,909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide41$76,743
EliquisApixaban66$51,840
MounjaroTirzepatide48$48,907
JardianceEmpagliflozin38$45,916
OzempicSemaglutide34$45,213
XifaxanRifaximin12$37,252
FarxigaDapagliflozin Propanediol24$29,935
TrulicityDulaglutide32$29,339
XareltoRivaroxaban18$27,244
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$20,915
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$15,769
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,552
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,274
Atorvastatin Calcium412$5,944
Losartan Potassium405$4,823

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$1,114$121,95775 claims
Lilly USA, LLCMounjaro, Trulicity$364$78,24580 claims
PfizerEliquis$184$51,84066 claims
Boehringer IngelheimJardiance$67$45,91638 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$215$37,25212 claims
AstraZenecaFarxiga, Breztri Aerosphere$204$36,20935 claims
GSKTrelegy Ellipta$46$9,55215 claims
AbbVieSynthroid$127$1,90732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Cleveland

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →